Kozak & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $170K | Sell |
2,034
-284
| -12% | -$23.8K | 0.03% | 88 |
|
2025
Q1 | $184K | Sell |
2,318
-574
| -20% | -$45.5K | 0.05% | 76 |
|
2024
Q4 | $287K | Buy |
2,892
+88
| +3% | +$8.73K | 0.07% | 62 |
|
2024
Q3 | $310K | Sell |
2,804
-94
| -3% | -$10.4K | 0.07% | 61 |
|
2024
Q2 | $365K | Sell |
2,898
-938
| -24% | -$118K | 0.09% | 53 |
|
2024
Q1 | $502K | Buy |
3,836
+23
| +0.6% | +$3.01K | 0.14% | 45 |
|
2023
Q4 | $452K | Sell |
3,813
-105
| -3% | -$12.4K | 0.14% | 43 |
|
2023
Q3 | $407K | Buy |
3,918
+44
| +1% | +$4.57K | 0.15% | 47 |
|
2023
Q2 | $443K | Buy |
3,874
+14
| +0.4% | +$1.6K | 0.18% | 50 |
|
2023
Q1 | $411K | Buy |
3,860
+154
| +4% | +$16.4K | 0.18% | 55 |
|
2022
Q4 | $411K | Hold |
3,706
| – | – | 0.2% | 47 |
|
2022
Q3 | $337K | Buy |
3,706
+159
| +4% | +$14.5K | 0.21% | 52 |
|
2022
Q2 | $323K | Buy |
3,547
+117
| +3% | +$10.7K | 0.22% | 48 |
|
2022
Q1 | $267K | Hold |
3,430
| – | – | 0.17% | 62 |
|
2021
Q4 | $267K | Buy |
3,430
+17
| +0.5% | +$1.32K | 0.17% | 62 |
|
2021
Q3 | $286K | Buy |
+3,413
| New | +$286K | 0.17% | 61 |
|
2020
Q4 | $255K | Buy |
+3,523
| New | +$255K | 0.2% | 60 |
|